chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site irritation, Injection site pruritus, Injection site warmth
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730332), concerns a 69-year-old, elderly, female patient. The patient was allergic to penicillin, amoxicillin and CEDAX. On 10-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: unknown, batch number: 179102). On the same day (10-Dec-2017), after vaccination, the patient experienced local irritation, redness, itchiness, warmness to the touch at the injection site. At the time of this report, the outcome of all the events was unknown. The reporter assessed this case as non-serious.
Age: 79.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730349), concerns a 79-year-old, elderly, female patient. The patient's current condition included diabetes mellitus, anaemia and HTN (hypertension) (all since an unspecified date). The patient had no known allergy (NKA). The patient's concomitant medications included iron, Calcium, Aspirin, Vitamin C, Multivitamin, carvedilol, Metformin and lisinopril and glipizide (in the morning of vaccination). On 06-Dec-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179301 and expiry date: not reported). On 07-Dec-2017, after one day of vaccination, the patient experienced bruising at least two inches below the injection site (deltoid muscle). The patient went to the physician office. The patient had no any pain and irritation at the injection site. No lab investigations were performed. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: This initial spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (regulatory reference number: 730435), concerning an 82-year-old, elderly, female patient. The patient did not have medical history and current illness. On 01-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 2), route of administration: intramuscular (reported as: UN), anatomical location: left arm, batch number: 178G02 (as reported) and expiry date: not reported). On the same day, after the vaccination, the patient developed severe pain in left arm due to which she was unable to move her arm completely. As of 12-Jul-2017, the patient felt much better, but still had pain in her left arm. On an unspecified date, the patient recovered from the event injected limb mobility decreased and had not yet recovered from the event pain in left arm. The reporter considered the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Petechiae
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730510), concerns a 71-year-old elderly female patient. The patient's current conditions included diabetic, high blood pressure, A-fib (atrial fibrillation). The patient's concomitant medications included metformin, ELIQUIS, Losartan, metoprolol, OTC unknown. On 15-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: injection (reported as SYR), anatomical location: left arm, batch number: 179301). On an unspecified date, the patient experienced severe petechial (as reported). At the time of report, the outcome of the event was unknown. The reporter assessed the case as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730676), concerns a 66-year-old, elderly, male patient. The patient received Pneumococcal 13 valent vaccine (on an unspecified date in 2016) (reported as one year prior). The patient's historical conditions, allergies, current illness and concomitant medications were not reported. On 03-Dec-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 178903 and expiry date: not reported) and non-company product PNEUMOVAX (dose: 1 DF (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: N0227704 and expiry date: not reported). On 04-Dec-2017, after one day of vaccinations, the patient experienced redness, swelling and rash at left upper arm. The patient did not seek any medical attention for the events (reported on 09-Dec-2017). On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Dizziness, Middle insomnia, Palpitations, Vertigo
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730687), concerns a 65-year-old, elderly female patient. The patient's medical history and concomitant medications were unknown. The patient had no known drug allergies and had no current illness. On 09-Nov-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 179103, expiry date: not reported). On the same day, after vaccination, the patient woke up in the middle of the night with light-headedness, vertigo, and palpitations. The patient had to lay down with head in the elevated position for relief. The patient consulted physician (Doctor of medicine-MD), who recommended with meclizine, but the patient took DRAMAMINE and natural ginger. After 3 days, vertigo resolved while standing, but the patient could not lay down in supine position without head raised. Palpitations lasted for 1 week. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3
Symptoms: Abdominal pain upper, Diarrhoea, Gastrointestinal pain, Muscle spasms, Pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730688), concerns a 66-year-old, elderly, male patient. The patient's historical condition included sinus infection (reported as 3 weeks ago). The patient had allergy to erythromycin. The concomitant medications included TYLENOL, fish/flaxseed/borage oil vitamin, Equate Multivitamin for adults 55 and older, Equate chewable aspirin, OCEAN saline nasal spray, Montelukast, fluticasone nasal spray for unknown indications. On 14-Dec-2017 (reported as above 11: 00 am), the patient was administered with FLUAD (TIV) (dose: 0.5 ml, batch number: 179603, route of administration, anatomical location, expiry date: not reported). On the same day after vaccination (by 3:00 pm), the patient experienced severe stomach cramps and diarrhoea. By 06:30 pm, the patient experienced projectile vomiting. After vomiting the patient experienced continuous severe cramps/pain and severe diarrhoea (totally liquid). The patient planned for an emergency room visit at midnight but, around 04:30 am next day morning (15-Dec-2017), cramps/pain in gut subsided a bit. Diarrhoea continued over 24 hours after vaccination. The patient had not sought any medical attention. At the time of this report, cramps and pain in gut was resolving, while the events stomach cramps, diarrhoea, projectile vomiting were not resolved. The reporter assessed this case as serious.
Age: 66.0
Sex: M
Vaccine: FLUA3
Symptoms: Vomiting projectile
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730688), concerns a 66-year-old, elderly, male patient. The patient's historical condition included sinus infection (reported as 3 weeks ago). The patient had allergy to erythromycin. The concomitant medications included TYLENOL, fish/flaxseed/borage oil vitamin, Equate Multivitamin for adults 55 and older, Equate chewable aspirin, OCEAN saline nasal spray, Montelukast, fluticasone nasal spray for unknown indications. On 14-Dec-2017 (reported as above 11: 00 am), the patient was administered with FLUAD (TIV) (dose: 0.5 ml, batch number: 179603, route of administration, anatomical location, expiry date: not reported). On the same day after vaccination (by 3:00 pm), the patient experienced severe stomach cramps and diarrhoea. By 06:30 pm, the patient experienced projectile vomiting. After vomiting the patient experienced continuous severe cramps/pain and severe diarrhoea (totally liquid). The patient planned for an emergency room visit at midnight but, around 04:30 am next day morning (15-Dec-2017), cramps/pain in gut subsided a bit. Diarrhoea continued over 24 hours after vaccination. The patient had not sought any medical attention. At the time of this report, cramps and pain in gut was resolving, while the events stomach cramps, diarrhoea, projectile vomiting were not resolved. The reporter assessed this case as serious.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730776), concerns a 70-year-old elderly female patient. The patient's historical vaccine included flu shot two years ago (had sore arm and pain which lasted for 5 days). however the patient's concomitant medications included OTC multivitamin with minerals, Low dose aspirin, Vitamin C for an unknown indication. On 02-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 05. ml, route of administration: intramuscular, anatomical location: left arm, batch number: not reported). On 03-Nov-2017, in the morning after inoculation, the patient experienced pain in the left arm. The patient had severe pain while raising her left arm to take off and put on clothes, to reach out to do anything like wash or style her hair, routine house work, put on or take off coat. It was reported that, from six and half weeks till then, there was small decrease in pain. The patient also stated that, it was bad medicine to inflict pain for ADL (activities daily living) on aging people. At the time of report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction was received with IRD on 07-Apr-2018: The sentence 'the patient's left arm sore' was corrected to 'the patient experienced pain in the left arm' in the narrative.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Asthenia, Electromyogram, Limb discomfort, Muscular weakness, Musculoskeletal stiffness
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730969), concerns a 72-year-old, elderly, male patient. The patient underwent IVC (Inferior vena cava) filter (unspecified date). The patient's historical condition included COPD (chronic obstructive pulmonary disease), BPH (benign prostatic hyperplasia), chronic renal disease and adrenal mass. The patient's current condition included eczema (since an unspecified date). The patient's concomitant medications included finasteride, Warfarin and tamsulosin for an unknown indication. On 20-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178701 and expiry date: not reported). On 02-Oct-2017, after 12 days of vaccination, the patient complained of pain, stiffness, discomfort, weakness and loss of strength in arm. On 17-Oct-2017, the patient called to physician office to report continued discomfort, weakness and loss of strength in arm. On 30-Nov-2017, nerve conduction velocity studies and EMG (electromyogram) were performed and results were not reported. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Nerve conduction studies, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 730969), concerns a 72-year-old, elderly, male patient. The patient underwent IVC (Inferior vena cava) filter (unspecified date). The patient's historical condition included COPD (chronic obstructive pulmonary disease), BPH (benign prostatic hyperplasia), chronic renal disease and adrenal mass. The patient's current condition included eczema (since an unspecified date). The patient's concomitant medications included finasteride, Warfarin and tamsulosin for an unknown indication. On 20-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178701 and expiry date: not reported). On 02-Oct-2017, after 12 days of vaccination, the patient complained of pain, stiffness, discomfort, weakness and loss of strength in arm. On 17-Oct-2017, the patient called to physician office to report continued discomfort, weakness and loss of strength in arm. On 30-Nov-2017, nerve conduction velocity studies and EMG (electromyogram) were performed and results were not reported. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3, PNC13, TDAP
Symptoms: Injection site pruritus, Injection site rash, Pruritus, Rash
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 731028), concerns an 82-year-old, elderly female patient. The patient's medical history, current illness, concomitant medications were unknown and had no known drug allergies (NKDA). On 10-Dec-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179003, expiry date: not reported), PREVNAR 13 (dose: 1 dose, route of administration: intramuscular, anatomical location: intramuscular, batch number: S7442T (as reported), expiry date: not reported), BOOSTRIX (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: 22X79 (as reported), expiry date: not reported). On the same day, the patient developed itching and rash on left arm. The patient experienced itching on left hand down to injection site and injection site rash on lower biceps described as a size of grapefruit. The patient was sent to urgent care and consulted physician. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Myalgia, X-ray normal
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS 731112), concerns a 76-year-old, elderly, male patient. The patient's current condition included high cholesterol (since an unspecified date) and the patient had no allergies. The concomitant medications include men 50 plus multivitamin (since an unspecified date). On 07-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: injection, anatomical location: left arm, batch number and expiry date: not reported). On 08-Dec-2017, after 1 day of vaccination, the patient experienced muscle pain between shoulder and elbow, especially in rotator cuff area. On an unspecified date, the x-ray was performed to the affected area and the results showed no bone damage. At the time of this report, the patient had not recovered from the event (myalgia). The reporter assessed this case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pain, Pain
Clinical narrative: This spontaneous case, reported by other health professionals to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 731142), concerns a 69-year-old elderly female patient. The patient's current conditions included blood pressure, rheumatoid arthritis, glaucoma, osteoporosis, heartburn. The patient's concomitant medications calcium and folic acid. On 31-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178503). On the same day, after vaccination, the patient experienced pain that radiated from the injection site in the deltoid to the elbow upon pressure on the site. On 19-Dec-2017, patient consulted the doctor as the pain got worse and told that she experienced pain after receiving vaccine. The patient inquired the doctor if the pain was normal which lasted for long, for which the doctor it was not a normal (reported as no). The doctor stated that the patient received the vaccine in the left arm, however the documentation made by the pharmacist who administered the vaccine was in the right arm. The patient could not talk with doctor for long time for first time or second time, as the doctor was busy with other patients. It was reported that, the patient could not be contacted in any of three phone numbers provided. However, the patient was asked by the doctor to come pharmacy. It was reported that, the doctor was contacted to get further information on patient's medications and about the injection site, but he was busy with other patients. Hence pharmacist had to leave a message to the doctor. It was reported that, the pharmacist could only infer the conditions of the patient based on the medications she received regularly from the pharmacy. At the time of report, the outcome of event was unknown. The reporter assessed the case as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Lethargy, Myalgia, Pyrexia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 731261), concerns a 77-year-old elderly female patient. The patient's medical history was not reported. The patient had no known allergies. On 04-Dec-2017, the patient was administered with FLUAD (dose: 0..5 ml (1 as reported), route of administration: injection (SYR as reported), anatomical location: left arm, batch number: 179301). On 19-Dec-2017, the patient experienced aches in all muscles and joints, a mild fever and general lethargy. At the time of report, the outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received on 07-Apr-2018: The sentence 'patient experienced overall aches in muscles and joints' was corrected to 'patient experienced aches in all muscles and joints'. The narrative was amended accordingly.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 731344) concerning a 70-year-old, elderly, female patient. The patient had no medical history, Concomitant medications included: NORVASC, ATIVAN, DETROL and REQUIP for an unknown indication. On 21-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 2 dose), batch number: 178323, anatomical location: left arm, route of administration, expiry date: not reported). On the same day after vaccination, the patient experienced pain in the lower arm (reported as dull). In addition, patient also experienced dull pain which was always consistent but there was no redness and swelling. The patient stated that the events were due to the flu shot (related). At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case-correction received with IRD 07-Apr-2018: The sentence "she also experienced dull pain" was reframed to "patient also experienced dull pain". No other changes were made in narrative.
Age: 73.0
Sex: M
Vaccine: FLUA3
Symptoms: Herpes zoster
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 731780), concerns a 73-year-old, elderly, male patient. The patient's historical conditions, allergies, current illness and concomitant medications were not reported. On 06-Nov-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, batch number: 179603, anatomical location and expiry date: not reported. On 06-Dec-2017, after 30 days of vaccination, the patient developed shingles. The patient went to the physician office visit. At the time of this report, the outcome of the event was unknown. The reporter assessed the event as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pruritus, Rash macular, Swelling face, Vaccination site reaction
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 732186), concerns a 75-year-old, elderly, female patient. The patient's medical history and concomitant medications were not reported. On 29-Dec-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178901 and expiry date: not reported). On 30-Dec-2017, after 1 day of vaccination, the patient experienced face swelling, itchy and splotchy red areas at vaccination site. No trouble breathing was noted. The lab tests were not reported. At the time of this report, the outcome of the events (injection site itching, swelling face, injection site reaction, injection site redness and rash macular) was unknown. The reporter assessed this case as non-serious.
Age: 82.0
Sex: M
Vaccine: FLUA3
Symptoms: Inflammation, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 732198), concerns an 82-year-old elderly male patient. The patient's historical vaccine included unspecified flu shot (two years ago, had pain which lasted for 5 days). The patient's concomitant medications included OTC multivitamin with minerals, Low dose aspirin, Vit C for an unknown indication. On 30-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: not reported). On 01-Dec-2017, 1 day after vaccination, the patient experienced pain and swelling of the hand and forearm area to the point where the patient had to seek medical treatment. As per the patient, event did not occur at injection site. The patient was given prednisolone for inflammation. No further treatment was needed. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Anxiety, Back pain, Coccydynia, Dysgeusia, Feeling hot
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733059), concerns a 67-year-old elderly female patient. The patient was allergic to penicillin and Clindamycin. On 09-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported) and was also administered with non-company suspect PNEUMOVAX (dose: reported as 2, route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day, few seconds after vaccination, the patient experienced bad and weird taste in the mouth, flushed, felt warmth, anxious/overwhelm feeling and immediately sat down. The patient had no trouble in breathing, wheezing and rash. After a few minutes later, the reaction moved to a dull throbbing pain in lower back/tailbone area. After 30 minutes, the reaction cleared but patient had a little pain in lower back. The patient had recovered from all the events except back pain. The reporter assessed this case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Flushing, Pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733059), concerns a 67-year-old elderly female patient. The patient was allergic to penicillin and Clindamycin. On 09-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported) and was also administered with non-company suspect PNEUMOVAX (dose: reported as 2, route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day, few seconds after vaccination, the patient experienced bad and weird taste in the mouth, flushed, felt warmth, anxious/overwhelm feeling and immediately sat down. The patient had no trouble in breathing, wheezing and rash. After a few minutes later, the reaction moved to a dull throbbing pain in lower back/tailbone area. After 30 minutes, the reaction cleared but patient had a little pain in lower back. The patient had recovered from all the events except back pain. The reporter assessed this case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Anxiety, Back pain, Coccydynia, Dysgeusia, Feeling abnormal
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733059), concerns a 67-year-old elderly female patient. The patient was allergic to penicillin and Clindamycin. On 09-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported) and was also administered with non-company suspect PNEUMOVAX (dose: reported as 2, route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day, few seconds after vaccination, the patient experienced bad and weird taste in the mouth, flushed, felt warmth, anxious/overwhelm feeling and immediately sat down. The patient had no trouble in breathing, wheezing and rash. After a few minutes later, the reaction moved to a dull throbbing pain in lower back/tailbone area. After 30 minutes, the reaction cleared but patient had a little pain in lower back. The patient had recovered from all the events except back pain. The reporter assessed this case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Feeling hot, Flushing, Pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733059), concerns a 67-year-old elderly female patient. The patient was allergic to penicillin and Clindamycin. On 09-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported) and was also administered with non-company suspect PNEUMOVAX (dose: reported as 2, route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On the same day, few seconds after vaccination, the patient experienced bad and weird taste in the mouth, flushed, felt warmth, anxious/overwhelm feeling and immediately sat down. The patient had no trouble in breathing, wheezing and rash. After a few minutes later, the reaction moved to a dull throbbing pain in lower back/tailbone area. After 30 minutes, the reaction cleared but patient had a little pain in lower back. The patient had recovered from all the events except back pain. The reporter assessed this case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733329), concerns a 66-year-old, elderly, female patient. The patient's historical conditions and current illness were unknown. The patient had no known allergies. The patient's concomitant medications were not reported. On 08-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179601 and expiry date: not reported). On the same day (08-Jan-2018), after the vaccination, the patient experienced typical injection site reactions which included redness, soreness and slightly raised induration of approximately 4 inches at the injection site. At the time of this report, the patient was recovering from the events . The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Erythema, Hyperaesthesia, Mobility decreased, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other non-health healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733789), concerns a 65-year-old, elderly female patient. The patient had no medical history, current illness and was not any medications. The patient was allergic to penicillin. On 11-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml, route of administration, anatomical location, batch number, expiry date: not reported). On 12-Jan-2018, the next day of vaccination, the patient developed red, swollen arm which was sensitive to touch and hard to move. The patient visited the physician and was prescribed with doxycycline hyclate 100 mg. On an unspecified date, the patient had not recovered from the events. The reporter assessed this case as non-serious. Non-significant case correction received 07-Apr-2018: The word sensitiveness was replaced with increased touch sensitivity in the case comment. No changes were made in the narrative.
Age: 79.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Musculoskeletal pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 733897), concerns a 79-year-old, female patient. The patient's current condition included hypothyroid, hypertension, allergy to antihistamines and no other current illness were reported. The concomitant drugs included amlodipine, metoprolol ER, losartan and levothyroxine for unknown indications. On 27-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179301, expiry date: not reported). On 28-Sep-2017, the next day of vaccination, the patient experienced pain in shoulder for a couple of weeks. The patient believed that the event was due to immunization given too high. The patient had an unrelated appointment with a physician who stated that, the shot might have hit tendon and caused mild tendonitis. No lab data was reported. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Back pain, Fatigue, Musculoskeletal pain, Nausea, Vomiting
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734118), concerns a 72-year-old, elderly, female patient. The patient's medical history and the concomitant medications were not reported. On 11-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, batch number: 178601, anatomical location and expiry date: not reported). On 12-Jan-2018, from day 1-3, after vaccination, the patient had fatigue, pain in back, shoulder and at 4, she experienced nausea and vomiting. The lab tests were not reported. At the time of this report, the outcome of the events (pain back, shoulder pain, fatigue, nausea and vomiting) was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 07-Apr-2018: The narrative statement was corrected. Non-significant case correction received with IRD 07-Apr-2018: The sentence in narrative was changed from 'the patient had fatigue, pain on back, shoulder and day 4, she experienced nausea and vomiting' to 'the patient experienced fatigue, pain in back, shoulder and on day 4, patient also experienced nausea and vomiting'. Narrative was amended accordingly.
Age: 42.0
Sex: F
Vaccine: FLUA3, PPV, TDAP, FLUA3, PPV, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734501), concerns a 42-year-old, adult female patient. The patient had allergy to drugs [azathioprine, ciprofloxacin, cyclobenzaprine HCL, duloxetine H; ENBREL; HUMIRA; INDOCIN; opioids - morphine analogues, tramadol HCL, ZOFRAN; duloxetine, tramadol]. The concomitant medications included meclizine, WELLBUTRIN, albuterol; COMPAZINE, prednisone, KLONOPIN, sumatriptan. On 17-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number: U5896CA (as reported), expiry date: not reported) [The reported batch number (U5896CA), did not match Seqirus batch numbers, however, because the reporter named Seqirus product FLUAD as the suspect vaccine, this report has been conservatively entered as a Seqirus case]. On the same day, the patient was also administered with PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: left arm, batch number: N025563 (as reported), expiry date: not reported) and ADACEL (dose: unknown, route of administration: intramuscular, anatomical location: right arm, batch number: U5864AA (as reported), expiry date: not reported). On 18-Jan-2018, the next day of vaccination, the patient experienced moderate pain, erythema located, mild itching at the vaccination site along with low-grade fever. The patient was treated with ibuprofen and last dose was taken at 08:00 AM. The patient denied chills, fever greater than 100 and N/V (nausea and vomiting). On an unspecified date, the patient consulted a physician due to the possible skin infection at left upper arm. The treatment included unspecified OTC (over the counter) analgesics and warm compression with transient relief. At the time of this report, the patient was afebrile. The outcome of other events (pain, erythema and itching at vaccination site) was unknown. The reporter assessed the case as non-serious.
Age: 42.0
Sex: F
Vaccine: FLUA3, PPV, TDAP, FLUA3, PPV, TDAP
Symptoms: Injection site pruritus, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734501), concerns a 42-year-old, adult female patient. The patient had allergy to drugs [azathioprine, ciprofloxacin, cyclobenzaprine HCL, duloxetine H; ENBREL; HUMIRA; INDOCIN; opioids - morphine analogues, tramadol HCL, ZOFRAN; duloxetine, tramadol]. The concomitant medications included meclizine, WELLBUTRIN, albuterol; COMPAZINE, prednisone, KLONOPIN, sumatriptan. On 17-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number: U5896CA (as reported), expiry date: not reported) [The reported batch number (U5896CA), did not match Seqirus batch numbers, however, because the reporter named Seqirus product FLUAD as the suspect vaccine, this report has been conservatively entered as a Seqirus case]. On the same day, the patient was also administered with PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: left arm, batch number: N025563 (as reported), expiry date: not reported) and ADACEL (dose: unknown, route of administration: intramuscular, anatomical location: right arm, batch number: U5864AA (as reported), expiry date: not reported). On 18-Jan-2018, the next day of vaccination, the patient experienced moderate pain, erythema located, mild itching at the vaccination site along with low-grade fever. The patient was treated with ibuprofen and last dose was taken at 08:00 AM. The patient denied chills, fever greater than 100 and N/V (nausea and vomiting). On an unspecified date, the patient consulted a physician due to the possible skin infection at left upper arm. The treatment included unspecified OTC (over the counter) analgesics and warm compression with transient relief. At the time of this report, the patient was afebrile. The outcome of other events (pain, erythema and itching at vaccination site) was unknown. The reporter assessed the case as non-serious.
Age: 79.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site erythema, Injection site swelling, Myalgia
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734651), concerns a 79-year-old elderly female patient. The patient had no known health conditions and drug allergies. However, the patient's concomitant medications included prednisolone AC 1% ear drops and brimonidine 0.2% eye drops. On 16-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179601) and non-company suspect PREVNAR 13 (dose: 1 as reported, route of administration: intramuscular, anatomical location: right arm, batch number: S92740 (as reported). On 23-Jan-2018, in the morning, 7 days after vaccination, the patient's vaccination site was bright red and swelled up. The patient said that after vaccination her muscle was normal but all of sudden experienced hurt in muscle. The patient was advised to contact or follow up with her doctor, to monitor the reaction for worsening of symptoms. The patient would be contacted to have an information on symptoms resolved or contacted the doctor. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 79.0
Sex: F
Vaccine: FLUA3, PNC13, FLUA3, PNC13
Symptoms: Injection site erythema, Myalgia, Vaccination site swelling
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734651), concerns a 79-year-old elderly female patient. The patient had no known health conditions and drug allergies. However, the patient's concomitant medications included prednisolone AC 1% ear drops and brimonidine 0.2% eye drops. On 16-Jan-2018, the patient was administered with FLUAD (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179601) and non-company suspect PREVNAR 13 (dose: 1 as reported, route of administration: intramuscular, anatomical location: right arm, batch number: S92740 (as reported). On 23-Jan-2018, in the morning, 7 days after vaccination, the patient's vaccination site was bright red and swelled up. The patient said that after vaccination her muscle was normal but all of sudden experienced hurt in muscle. The patient was advised to contact or follow up with her doctor, to monitor the reaction for worsening of symptoms. The patient would be contacted to have an information on symptoms resolved or contacted the doctor. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Chills, Erythema, Pyrexia, Urticaria
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 734705), concerns a 67-year-old, elderly female patient. The patient's current conditions included, environmental and dairy allergies. On 04-Dec-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as unknown), route of administration, anatomical location, batch number, expiry date: not reported). On the same day, after the vaccination, the patient experienced chills, fever and red welts. The patient reported the events to the physician and pharmacy. On an unspecified date, the patient was recovered from the events. The reporter assessed the case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Erythema, Injection site induration, Injection site mass, Swelling
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS (VAERS ID: 734783), concerns a 69-year-old, elderly, female patient. The patient's historical conditions included hypothyroidism, osteomalacia and herpes simplex (unspecified date). The patient's current conditions included arrhythmia and hypertension (since an unspecified date). The patient's concomitant medications were not reported. On 18-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179401 and expiry date: not reported). On 19-Jan-2018, after 1 day of vaccination (reported as: called 48 hrs after vaccination), the patient complained of swollen red area of about 6 inches in diameter and felt like a hard lump at the injection site. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 34.0
Sex: U
Vaccine: FLUA3, FLUA3
Symptoms: Dry mouth, Heart rate abnormal, Insomnia, Pruritus, Tachycardia
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 735507), concerns a 34-year-old, adult patient of an unspecified gender. The patient's historical vaccine included influenza vaccine which caused tachycardia, dry mouth, itching, weak heart rate and insomnia. The patient's historical condition included asthma (treated with prednisone 10mg) and psychosis (unspecified date). The patient had no current illness. The patient's concomitant medications included meloxicam, estradiol, spironolactone, IP6 (as reported) and inositol for an unknown indication. On 25-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: unknown and expiry date: not reported). On the same day, after the vaccination, the patient experienced tachycardia, dry mouth, itching, weak heart rate and insomnia for 3 days. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Erythema, Limb discomfort, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 735671), concerning a 72-year-old, elderly, female patient. The patient current condition included: diabetes mellitus (DM). The patient was allergic to penicillin. Concomitant medications included: escitalopram, glipizide, atorvastatin and hydrochlorothiazide. On 16-Jan-2018, the patient was administered with FLUAD (dose: 0.5 ml, anatomical location: right arm, batch number: 179103, route of administration, expiry date: not reported). On the same day, the patient was also administered with non-company suspect drug PNEUMOVAX (dose: 1 DF, anatomical location: left arm, batch number: N02656, route of administration, expiry date: not reported). On the same day after administration of vaccines, the patient's left arm was swollen and red. The patient took ibuprofen overnight for the events. On 17-Jan-2018 at 09:30 until noon, the patient's arm was swollen and experienced discomfort. The patient had no headache or pain. It was reported that, the patient required no further intervention. The patient had recovered from all the events (redness, limb discomfort and swollen arm). The reporter assessed the case as non-serious. Non-significant case correction received 07-Apr-2018: The sentence 'the patient's arm was swollen and red' was corrected to 'the patient's left arm was swollen and red'. Case comment was updated (from swollen arm to swelling of left arm). The narrative was amended accordingly.
Age: 71.0
Sex: F
Vaccine: FLUA3, PPV, FLUA3, PPV
Symptoms: Chills, Fatigue, Muscular weakness, Pain in extremity, Peripheral swelling
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 07-Apr-2018 by Seqirus from VAERS (VAERS ID: 735801), concerns a 71-year-old, elderly, female patient. The patient was allergic to sulfa, penicillin (PCN) and cephalosporins. The patient's current conditions included hypertension, degenerative disc/joint disease, and polyarthritis. The patient had no other current illness. The patient's concomitant medications include metoprolol, HCTZ, lisinopril, gabapentin, tramadol, MOBIC, PEPCID AC, ASA, fluticasone, TYLENOL PM, CENTRUM SILVER, CITRACAL calcium plus vitamin D, Fish Oil, TYLENOL extra strength for an unknown indication. On 22-Jan-2018, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179523) and PNEUMOVAX (dose: 1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: as reported N030111). On 23-Jan-2018, one day after vaccination, the patient experienced painful arm, swollen with a rash from hand's width above the elbow up and over the shoulder (as reported). Subsequently, the patient was exhausted, had chills, body muscle weakness for 5 days. It was reported that, the patient was not seen in clinic. On an unknown date, the patient had recovered from all the events. The reporter assessed this case as non-serious. Non-significant case correction was received with IRD 07-Apr-2018: The misspelling was corrected in the case comment. No changes were done in narrative.